Gregor Diagnostics

Gregor Diagnostics Inc. is a molecular diagnostics company dedicated to developing innovative screening tests for prostate cancer. Founded in 2016 and headquartered in Madison, Wisconsin, the company has created a technology that utilizes seminal fluid as a sample source. This advanced testing method enables the early detection of prostate cancer and helps differentiate between indolent and aggressive forms of the disease. By providing a reliable assessment of cancer aggressiveness, Gregor Diagnostics aims to assist physicians in reducing the risks of overdiagnosis and overtreatment of less severe cases while enhancing the management of more aggressive prostate cancer.